Stay updated on Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page.

Latest updates to the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page
- ChecktodayChange DetectedThe page history now includes Revision: v3.3.4 and removes Revision: v3.3.3, reflecting a minor maintenance update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.3.3 was added to the history, and the HHS Vulnerability Disclosure entry and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check50 days agoChange DetectedThe Record History shows a new entry for version 15 on 2025-11-11 with Revision: v3.3.2, and the prior revision v3.2.0 entry dated 2025-11-12 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check57 days agoChange DetectedOn 2025-11-12, Adverse Events, Outcome Measures (Results), Participant Flow, and Study Status were added to the Record History for NCT04221438. The 2025-10-28 update added item 14 under Study Status.SummaryDifference1%

- Check72 days agoChange DetectedRecord History shows new versions (e.g., 2025-04-29, 2025-05-22, 2025-06-04) with updates to Study Status, Recruitment Status, and Outcome Measures.SummaryDifference0.1%

- Check100 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference11%

Stay in the know with updates to Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj. Encorafenib/Binimetinib in Melanoma: Clinical Trial page.